Mechanism and Effect of Beta-Blockers on Pancreatic Adenocarcinoma: A Literature Review

Pancreatic adenocarcinoma has a poor 5-year survival rate despite many advancements in pharmacotherapies. Studies have suggested the involvement of β-adrenergic pathway in the progression of pancreatic adenocarcinoma. Animal experiments and retrospective trials have reported the use of beta-blockers...

Descripción completa

Detalles Bibliográficos
Autores principales: Upadhyaya, Vandan D., Douedi, Steven, Garcia, Brandon, Gonzalez, Jimmy, Udongwo, Ndausung, Wei, Juanqin, Nai, Qiang, Asif, Arif, Sen, Shuvendu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elmer Press 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7781287/
https://www.ncbi.nlm.nih.gov/pubmed/33447308
http://dx.doi.org/10.14740/jocmr4387

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7781287/
https://www.ncbi.nlm.nih.gov/pubmed/33447308
http://dx.doi.org/10.14740/jocmr4387

Ejemplares similares